1.上海中医药大学附属曙光医院肝二科(上海 201203)
陈天阳,男,硕士研究生,住院医师,主要从事中西医结合防治肝病及传染病工作
成扬,主任医师,博士研究生导师;E-mail:drchengyang@126.com
扫 描 看 全 文
陈天阳, 成扬. 成扬从郁论治非酒精性脂肪性肝病经验[J]. 上海中医药杂志, 2021,55(9):34-37,49.
Tianyang CHEN, Yang CHENG. Cheng Yang’s experience in treating non-alcoholic fatty liver disease from the perspective of depression[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(9):34-37,49.
陈天阳, 成扬. 成扬从郁论治非酒精性脂肪性肝病经验[J]. 上海中医药杂志, 2021,55(9):34-37,49. DOI: 10.16305/j.1007-1334.2021.2104006.
Tianyang CHEN, Yang CHENG. Cheng Yang’s experience in treating non-alcoholic fatty liver disease from the perspective of depression[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(9):34-37,49. DOI: 10.16305/j.1007-1334.2021.2104006.
介绍成扬教授从郁论治非酒精性脂肪性肝病(NAFLD)的经验。成教授认为NAFLD发病与人的精神压力、自身心理因素和生活方式密切相关,可导致抑郁症发病率升高,而重度抑郁症以及广泛性焦虑症在NAFLD患者中更常见,因此认为NAFLD符合郁证范畴,也符合因病致郁、因郁致病特点,故NAFLD的中医药治疗以疏肝理气解郁为主,同时结合运动及心理疗法。
Professor Cheng Yang’s experience in treating non-alcoholic fatty liver disease (NAFLD) from perspective of depression was introduced. Professor Cheng Yang believed that the incidence of NAFLD was closely related to people’s mental pressure, psychological factors and lifestyle, which could lead to increased incidence of depression, while major depression and generalized anxiety disorder were more common in NAFLD patients, which conformed to the characteristics of "depressive disorder caused by illness" and " illness caused by depression" . Therefore, the treatment of NAFLD was mainly to soothe the liver, regulate qi and relieve depression. Meanwhile, it was combined with sports and psychological therapy.
郁证非酒精性脂肪性肝病疏肝理气解郁因病致郁因郁致病
depression syndromenon-alcoholic fatty liver diseasesoothing the liver regulating qi and relieving depressiondepressive disorder caused by illnessillness caused by depression
盛夏. 从肝论治郁证在临床中的应用[J]. 中国民族民间医药,2013, 22(4): 55.
成扬,杨雪丽,蒋健. 中医药治疗郁证的研究进展[J]. 中国中医药现代远程教育,2021, 19(6): 193-196.
范晓鹏,李新友,高帅,等. 慢性肝病患者中医郁证不同分型与氧化损伤的关系[J]. 中西医结合肝病杂志,2016, 26(6): 344-345.
樊昕. 略论郁证从肝论治[J]. 陕西中医,1989, 10(3): 118-119.
沈月红,汪永胜. 从心肝相关理论结合情志疗法论治失眠[J]. 江苏中医药,2016, 48(4): 44-46.
韩晶杰,烟建华. 肺与抑郁症的关系探讨[J]. 中华中医药学刊,2005, 23(6): 1054-1054.
宋萍,詹向红,杨丽萍,等. 五脏与抑郁症发病探析[J]. 中华中医药杂志,2013, 28(10): 2851-2854.
WOOD G C, XIN C, ARGYROPOULOS G, et al. A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains[J]. Sci Rep, 2017(7): 43238.
张声生,吴震宇,陈剑明,等. 三七总皂苷改善高脂诱导脂肪肝大鼠模型氧化应激及胰岛素抵抗的研究[J]. 中国中西医结合杂志,2014, 34(1): 56-61.
陈天阳,侯天禄,成扬,等. miR-199a-3p对高脂饮食诱导的非酒精性脂肪性肝病模型小鼠肝脏脂肪变性的影响[J]. 胃肠病学和肝病学杂志,2018, 27(10): 1115-1118.
MARGARITA P, EVANGELOS C. Diagnosis of non-alcoholic fatty liver disease (NAFLD): Current concepts[J]. Curr Pharm Des, 2018, 24(38): 4574-4586.
ZHANG X, JI X T, WANG Q, et al. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD) [J]. Protein Cell, 2018, 9(2): 164-177.
梁乾飞,王亚东,赵彩彦. 河北省居民非酒精性脂肪性肝病的认知调查与分析[J]. 中华肝脏病杂志,2017, 25(10): 760-765.
SOTO-ANGONA Ó, ANMELLA G, VALDÉS-FLORIDO M J, et al. Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches[J]. BMC Med, 2020, 18(1): 261.
廖倩,郑怡,刘羞菲,等. 中老年人群非酒精性脂肪肝与抑郁症的相关性研究[J]. 第三军医大学学报,2017, 39(19): 1954-1959.
陈天阳,成扬. 成扬运用升降散合小柴胡汤治疗非酒精性脂肪性肝病合并高脂血症经验探析[J]. 中西医结合肝病杂志,2017, 27(6): 378-380.
MACAVEI B, BABAN A, DUMITRASCU D L. Psychological factors associated with NAFLD/NASH: a systematic review[J]. Eur Rev Med Pharmacol Sci, 2016, 20(24): 5081-5097.
蒋健. 郁证发微(一)——郁证形态论[J]. 上海中医药杂志,2015, 49(8): 4-7.
郑珏. 非酒精性脂肪肝辨证分型与体重指数、血脂的关系[J]. 云南中医学院学报, 2012, 35(6): 28-31.
李文华, 赵晖, 付士地,等. 非酒精性脂肪肝的超声表现与中医辨证分型的关系[J]. 中国实用医药, 2015, 10(26): 106-107.
段娜, 李志红, 黄一茜,等. 非酒精性脂肪肝中医证候分布特点及相关因素的临床分析[J]. 新中医, 2012, 44(7): 43-45.
连雅君, 王庆国, 程发峰,等. 基于数据挖掘探讨非酒精性脂肪肝证型、证素的分布规律[J]. 中医药导报,2017, 23(5): 28-31.
YOUSSEF N A, ABDELMALEK M F, BINKS M, et al. Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease.[J]. Liver International, 2013, 33(7): 1062-1070.
ELWING J E, LUSTMAN P J, WANG H L, et al. Depression, anxiety, and nonalcoholic steatohepatitis[J]. Psychosom Med, 2006, 68(4): 563-569.
童送文. 小柴胡汤加减治疗非酒精性脂肪肝临床疗效观察[J]. 亚太传统医药,2017, 13(11): 133-134.
潘丰满,黄江荣. 柴胡疏肝散治疗非酒精性脂肪肝82例临床观察[J]. 时珍国医国药,2009, 20(8): 2010-2011..
乔成安. 逍遥散加减治疗非酒精性脂肪肝30例[J]. 陕西中医, 2010, 31(9): 1118-1119.
王平,罗芳,刘晓晖. 丹栀逍遥散治疗非酒精性脂肪肝的疗效观察[J]. 云南中医中药杂志,2017, 38(7): 35-36.
徐中菊,王慧,顾婷婷,等. 丹芍疏肝颗粒对不同中医证型非酒精性脂肪肝临床疗效研究[J]. 辽宁中医杂志,2016, 43(4): 771-773.
李萍,束晓玉. 自拟解郁疏肝汤治疗肝郁气滞型非酒精性脂肪肝临床疗效及作用机制研究[J]. 四川中医,2017, 35(1): 94-96.
程红杰,牛少强. 四逆散加味治疗非酒精性脂肪肝40例疗效观察[J]. 北京中医药, 2012, 31(10): 61-763.
黄欣,王海洋,孙玉英. 杨震教授应用清肝化郁法治疗非酒精性脂肪肝2则[J]. 陕西中医,2016, 37(1): 19-119.
THORP A, STINE J G. Exercise as medicine: the impact of exercise training on nonalcoholic fatty liver disease[J]. Curr Hepatol Rep, 2020, 19(4): 402-411.
HASHIDA R, KAWAGUCHI T, BEKKI M, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review[J]. J Hepatol, 2017, 66(1): 142-152.
许瑞平,张晓文,赵广才. 运动改善生理和心理健康的研究进展[J]. 甘肃医药,2013, 32(6): 422-424.
蒋健. 郁证发微(三)—郁证治疗论[J]. 上海中医药杂志,2015, 49(10): 4-7.
杨金仙,白尊艳. 中医情志护理对非酒精性脂肪性肝病的影响[J]. 护理与康复,2019, 18(6): 84-86.
余荻,杨旭瑶,赵锦涵,等. 焦虑与非酒精性脂肪性肝病的关系[J]. 临床肝胆病杂志,2020, 36(11): 2589-2592.
0
浏览量
322
下载量
0
CSCD
2
CNKI被引量
关联资源
相关文章
相关作者
相关机构